Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 928 M952 M969 M1.03 B986 M 3.94 B Research & development ————— — Operating income 943 M823 M889 M853 M1.3 B 3.86 B Non-Operating Income, Total 26 M25 M29 M9 M454 M 517 M Interest expense, net of interest capitalized 204 M206 M206 M205 M205 M 822 M Non-Operating Income, excl. Interest Expenses -204 M-206 M-206 M-233 M208 M -437 M Unusual income/expense 26 M25 M29 M37 M41 M 132 M Pretax income 765 M642 M712 M681 M1.13 B 3.17 B Equity in earnings 56 M61 M64 M83 M51 M 259 M Taxes 143 M120 M133 M37 M226 M 516 M Non-controlling/minority interest 216 M234 M237 M273 M204 M 948 M After tax other income/expense -2 M3 M2 M3 M-2 M 6 M Net income before discontinued operations 622 M522 M579 M644 M906 M 2.65 B Discontinued operations ————— — Net income 622 M522 M579 M644 M906 M 2.65 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 406 M288 M342 M371 M702 M 1.7 B Basic earnings per share (Basic EPS) 4.313.163.894.258.09 19.39 Diluted earnings per share (Diluted EPS) 4.273.143.864.228.01 19.23 Average basic shares outstanding 94.24 M91.14 M87.95 M90.15 M86.8 M — Diluted shares outstanding 95.02 M91.79 M88.61 M90.83 M87.6 M — EBITDA 4.46 B4.44 B3.29 B3.28 B3.41 B 14.42 B EBIT 4.25 B4.23 B3.08 B3.05 B3.18 B 13.54 B Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 206 M208 M218 M231 M229 M 886 M